Tuberculosis: Recommendations for screening, prevention, and treatment

Postgraduate Medicine

Volumn 100, Issue 4, 1996, Pages 201-220

  Moffitt, Maricela P ^b   Wisinger, David B ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRIDOXINE; RIFAMPICIN; STREPTOMYCIN SULFATE;

ANTIBIOTIC RESISTANCE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; REVIEW; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; HUMANS; OCCUPATIONAL DISEASES; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 10244279283     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.1996.10.102     Document Type: Article

References (17)

1. Centers for Disease Control. Screening for tuberculosis and tuberculous infection in high-risk populations: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990; 39 (RR-8): 1 – 7
2. Rieder HL, Cauthen GM, Comstock GW, et al. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989; 11: 79 – 98
3. Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1995; 44 (RR-11): 19 – 34
4. US Department of Health and Human Services. Core curriculum on tuberculosis: what the clinician should know. 3d ed. Atlanta: Centers for Disease Control and Prevention, 1994: 7
5. Bass JB Jr. Tuberculin test, preventive therapy, and elimination of tuberculosis. Am Rev Respir Dis 1990; 141: 812 – 3
6. Sbarbaro JA. Skin testing in the diagnosis of tuberculosis. Semin Respir Infect 1986; 1 (4): 234 – 8
7. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990; 142 (3): 725 – 35 [Erratum, Am Rev Respir Dis 1990; 142 (6 Pt 1): 1470 ]
8. Haas DW, Des Prez RM. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 2217
9. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149 (5): 1359 – 74
10. Centers for Disease Control. The use of preventive therapy for tuberculous infection in the United States: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 1990; 39 (RR-8): 9 – 12
11. Snider DE Jr, Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis 1992: 145 (2 Pt 1): 494 – 7
12. Kopanoff DE, Snider DE Jr, Caras GJ. Isoniazid-related hepatitis: a US Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117 (6): 991 – 1001
13. Centers for Disease Control. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1993; 42 (RR-7): 1 – 8 [Erratum, MMWR 1993; 42 (27):536]
14. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271 (9): 665 – 71
15. Snider DE Jr, Roper WL. The new tuberculosis. (Editorial) N Engl J Med 1992; 326 (10): 703 – 5
16. US Department of Health and Human Services. Centers for Disease Control guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994; Notice. Part II. Federal Register, Oct 28, 1994; 59: 54202 – 303
17. Gostin LO. Controlling the resurgent tuberculosis epidemic: a 50-state survey of TB statutes and proposals for reform. JAMA 1993; 269 (2): 255 – 61